CMPX: Compass Therapeutics, Inc. Common Stock Company Profile & Statistics

Compass Therapeutics, Inc. Common Stock Profile

About

Compass Therapeutics Inc. is a clinical-stage biopharmaceutical company developing proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematologic malignancies. The company's lead product candidate includes CTX-471. Compass Therapeutics Inc. is based in Boston, MA.

Info & Links

CEO

Headquarters

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

Auditor

Share holders

Employees

Compass Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

954.47M

Enterprise Value

923.82M

Enterprise Value/EBITDA(ttm)

-12.65

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

4.82

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-43.61%

Return on Invested Capital(ttm)

-51.20%

Return on Assets(ttm)

-38.05%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

Gross Profit(ttm)

0.00

EBITDA(ttm)³

-73.04M

Net Income Available to Common(ttm)

-66.49M

Diluted EPS(ttm)

-0.43

Share Statistics

Beta (5Y Monthly)

1.48

52-Week Change

146.42%

S&P 500 52-Week Change

13.39%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

126.42M

% Held by Insiders

29.80%

% Held by Institutions

68.43%

Balance Sheet

Total Cash(mrq)

208.91M

Total Cash Per Share(mrq)

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

15.02%

Quick Ratio(mrq)

15.02%

Book Value Per Share(mrq)

1.10

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.31

Free Cash Flow(ytd)

-49.17M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.